JPS59108745A - （ｓ）（−）ベタキソロ−ル、その製造方法およびそれを含有する医薬 - Google Patents

（ｓ）（−）ベタキソロ−ル、その製造方法およびそれを含有する医薬

Info

Publication number
JPS59108745A
JPS59108745A JP58220484A JP22048483A JPS59108745A JP S59108745 A JPS59108745 A JP S59108745A JP 58220484 A JP58220484 A JP 58220484A JP 22048483 A JP22048483 A JP 22048483A JP S59108745 A JPS59108745 A JP S59108745A
Authority
JP
Japan
Prior art keywords
salt
betaxolol
treatment
item
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58220484A
Other languages
English (en)
Japanese (ja)
Inventor
ジヤン・ビネ
フイリペ・マヌリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of JPS59108745A publication Critical patent/JPS59108745A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58220484A 1982-11-22 1983-11-21 （ｓ）（−）ベタキソロ−ル、その製造方法およびそれを含有する医薬 Pending JPS59108745A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8219506A FR2536390B1 (fr) 1982-11-22 1982-11-22 Isomere s du betaxolol, sa preparation et son application en therapeutique
FR8219506 1982-11-22

Publications (1)

Publication Number Publication Date
JPS59108745A true JPS59108745A (ja) 1984-06-23

Family

ID=9279382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58220484A Pending JPS59108745A (ja) 1982-11-22 1983-11-21 （ｓ）（−）ベタキソロ−ル、その製造方法およびそれを含有する医薬

Country Status (13)

Country Link
JP (1) JPS59108745A (it)
AU (1) AU559204B2 (it)
BE (1) BE898277A (it)
CH (1) CH658049A5 (it)
DE (1) DE3341983A1 (it)
FR (1) FR2536390B1 (it)
GB (1) GB2130585B (it)
IE (1) IE56282B1 (it)
IL (1) IL70282A0 (it)
IT (1) IT1169131B (it)
LU (1) LU85099A1 (it)
NL (1) NL8304000A (it)
ZA (1) ZA838682B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8609190A1 (es) * 1985-02-07 1986-07-16 Pharma Investi S A Un procedimiento para preparar eteres fenolicos
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
US20100113606A1 (en) * 2008-11-05 2010-05-06 Auspex Pharmaceuticals, Inc. Aminopropanol modulators of beta-1 adrenergic receptor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5285146A (en) * 1975-11-06 1977-07-15 Synthelabo New phenol ether derivatives and process for manufacture thereof
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5285146A (en) * 1975-11-06 1977-07-15 Synthelabo New phenol ether derivatives and process for manufacture thereof
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent

Also Published As

Publication number Publication date
CH658049A5 (fr) 1986-10-15
GB2130585B (en) 1985-12-04
IL70282A0 (en) 1984-02-29
IE832716L (en) 1984-05-22
FR2536390B1 (fr) 1986-03-21
DE3341983A1 (de) 1984-05-24
LU85099A1 (fr) 1985-07-17
FR2536390A1 (fr) 1984-05-25
BE898277A (fr) 1984-05-21
AU2155883A (en) 1984-05-31
IT1169131B (it) 1987-05-27
IE56282B1 (en) 1991-06-05
GB8331038D0 (en) 1983-12-29
GB2130585A (en) 1984-06-06
NL8304000A (nl) 1984-06-18
IT8323803A0 (it) 1983-11-21
AU559204B2 (en) 1987-02-26
ZA838682B (en) 1985-03-27

Similar Documents

Publication Publication Date Title
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
US8017786B2 (en) Substituted β-phenyl-α-hydroxy-propanoic acid, synthesis method and use thereof
CN106573934B (zh) 瞬时受体电位a1离子通道的抑制
DE69215595T2 (de) Isochinolin-5-yl-Sulfonsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
CN106800537B (zh) 丁苯酞-替米沙坦杂合物及其制备方法和用途
TW200825072A (en) Soluble epoxide hydrolase inhibitors
EP3638239A1 (en) Methods of treating rbp4 related diseases with triazolopyridines
JPS62169763A (ja) 心血管薬、抗ヒスタミン薬および分泌抑制薬としてのｎ−置換−アリ−ルアルキル−および−アリ−ルアルキレン−アミノ複素環化合物
DE2020864C3 (de) p-Substituierte 1-Phenoxy-3-alkylaminopropan-2-ole, Herstellungsverfahren und Arzneimittel
US20060041139A9 (en) Substituted alkyl amido piperidines
JP2004534802A (ja) 重水素化Ｎ−及びα−置換ジフェニルアルコキシ酢酸アミノアルキルエステル並びにこれを含有する医薬品
DE1937477B2 (de) 1 -Phenoxy-2-hydroxy-3-( 1 -methylcycloalkylamino)-propane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CN114920743A (zh) 一种吲哚生物碱及其制备方法与应用
DE60225694T2 (de) Neues polymorph von fexo-fenadin
JPS59108745A (ja) （ｓ）（−）ベタキソロ−ル、その製造方法およびそれを含有する医薬
SU1367855A3 (ru) Способ получени N-(3-алкиламинопропил)-N-фенилмочевины или их фармакологическиприемлемых солей
NO150734B (no) Fremgangsmaate ved produksjon av olje eller gass gjennom en broenn som strekker seg gjennom en olje- eller gassholdig formasjon
JPS5826886A (ja) テオブロミンのピペラジン誘導体、該誘導体の製造方法及び該誘導体を含有する医薬組成物
DD205682A5 (de) Verfahren zur herstellung von (-)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en und seinen salzen
CN103483282B (zh) 苯基取代的三唑酰胺类化合物及用途
US9895340B2 (en) Fluorinated benzofuran derivatives
JP2011506485A (ja) 糖尿病治療用のオクタヒドロキノリジン
DE2734270C2 (it)
KR101172472B1 (ko) 4급 암모늄 화합물, 그 제조 방법, 뇌혈관 장애 치료제 및 심장 질환 치료제
AU7911487A (en) Resolution of dl-methyl 3-(4-(2-hydroxy-3-isopropylamino) propoxy)phenylpropionate((dl-esmolol))